Chris Ellis

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

Pedro M. Folegatti, Duncan Bellamy, Amy Flaxman et al. · Vaccines · 2019 · 27 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol

Hannah Swayze, Julie Allen, Pedro M. Folegatti et al. · F1000Research · 2019 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)

Christopher Butler, Chris Ellis, Pedro M. Folegatti et al. · Vaccines · 2021 · 13 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study

Thomas G. Evans, Flora Castellino, Monika Kowalik Dobczyk et al. · The Lancet Microbe · 2024 · 13 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17